Study of an investigational drug for migraine attacks
Part of Brain & nervous system clinical trials.
This trial tests a new oral medication to treat migraine attacks in adults who get them regularly. It might reduce the number of attacks and improve your quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older.
- You have been diagnosed with migraine (with or without aura) for at least 1 year.
- You have at least 2 migraine attacks per month that need treatment, over the past 3 months.
- You have fewer than 15 headache days per month (migraine or non-migraine) over the past 3 months.
- If you take preventive migraine medicine, you must have been on a stable dose for at least 3 months.
- You have not taken migraine-specific treatments (like CGRP blockers) within the required washout period.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational tablet called BR005-036C for quickly treating migraine attacks in adults. If you have frequent migraines but not too many headache days overall, you might be able to join and help see if this new medicine is safe and effective.
This study tests new ways to monitor how well preventive migraine treatments are working. It is for people with chronic migraine who may be starting or already using preventive medications.
This trial is testing new ways to treat migraine attacks. It is for adults in Denmark who have migraine on a few days each month and have used triptan rescue medicines.
This study tests an investigational medication called NB001 for treating migraine attacks as they happen. If you have frequent migraines, this treatment might help reduce the severity or shorten the duration of your attacks.
This study tests whether a substance called CGRP (a protein linked to migraines) can safely trigger a migraine with aura in people who already have this condition. You'll receive an infusion and be monitored to see how your body responds.
This study looks at ways to help children and teens with migraine headaches by testing a care approach that includes access to evidence-based treatment. It may help if your child has frequent migraine headaches and is starting (or not already on) certain migraine-preventive medicines.
Hear when a new Migraine, With or Without Aura trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.